PULM
Pulmatrix, Inc.Company Information
- Company Name
- Pulmatrix, Inc.
- CIK
- CIK0001574235
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- PULM: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- PULM
SEC filing data through
Insider Sentiment
- Last purchase
- 2018-04-03
- Last sale
- 2015-06-17
- Shares purchased (TTM)
- 2,627,000
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 334,524
- Shares outstanding
- 3,652,285
- Ownership
- 9.16%
Earnings Market Reaction
- Filing date
- 2026-08-13
- Price on filing date
- —
- 1-month reaction
- -7.95%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 2 | 3 | 4 | 5 | 6 | 8 | 10 | 11 | 12 | 16 | 19 | 21 | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 3 | 4 | 4 | 5 | 6 | 8 | 10 | 11 | 16 | 18 | 21 | 23 | ||||||
| Accounts Receivable Net Current | - | - | - | - | - | 0 | - | 0 | 1 | 1 | 1 | 1 | ||||||
| Restricted Cash Current | 1 | 1 | - | - | - | - | - | - | 1 | - | - | 0 | ||||||
| Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | ||||||
| Property Plant And Equipment Net | - | - | - | - | - | - | - | - | - | 1 | 1 | 1 | ||||||
| Restricted Cash Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | ||||||
| Operating Lease Right Of Use Asset | - | - | - | - | - | - | - | - | - | 10 | 10 | 11 | ||||||
| Other Assets Noncurrent | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 3 | 4 | 4 | 5 | 6 | 8 | 10 | 12 | 16 | 30 | 34 | 37 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Accounts Payable Current | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 2 | 1 | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 3 | 4 | 4 | ||||||
| Accrued Liabilities And Other Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 1 | 3 | ||||||
| Operating Lease Liability Current | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | ||||||
| Deferred Revenue Noncurrent | - | - | - | - | - | - | - | - | - | - | 4 | 4 | ||||||
| Operating Lease Liability Noncurrent | - | - | - | - | - | - | - | - | - | 8 | 8 | 8 | ||||||
| Liabilities | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 11 | 16 | 17 | ||||||
| Deferred Revenue Current | - | - | - | - | - | - | - | - | 0 | 0 | 1 | 1 | ||||||
| Preferred Stock Value | 1 | 1 | - | - | - | - | - | - | - | - | - | - | ||||||
Stockholders Equity | ||||||||||||||||||
| Stockholders Equity | 3 | 4 | 4 | 5 | 6 | 7 | 9 | 11 | 13 | 19 | 18 | 20 | ||||||
| Additional Paid In Capital | 306 | 306 | 306 | 306 | 306 | 306 | 306 | 306 | 306 | 306 | 306 | 305 | ||||||
| Retained Earnings Accumulated Deficit | -305 | -303 | -302 | -301 | -301 | -299 | -297 | -295 | -293 | -287 | -288 | -286 | ||||||
| Liabilities And Stockholders Equity | 3 | 4 | 4 | 5 | 6 | 8 | 10 | 12 | 16 | 30 | 34 | 37 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | ||||||
| Common Stock Shares Issued | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | ||||||
| Shares Outstanding | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialPulmatrix, Inc. (PULM) — SEC Financial Statements & Analysis
Pulmatrix, Inc. (PULM) is a pharmaceutical preparations company, incorporated in DE. Pulmatrix, Inc. trades on Nasdaq as: PULM. Pulmatrix, Inc. (PULM)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13. Based on that filing, Pulmatrix, Inc. carries a market cap of $6.21M, a P/E ratio of -1.54x, a P/B ratio of 2.43x, a P/S ratio of 3.01x, an enterprise value of $4.04M, and an EV/EBITDA multiple of -0.98x. On profitability, it posts an operating margin of -105.52%, a net margin of -105.64%, a Return on Equity (ROE) of -98.74%, a Return on Assets (ROA) of -85.74%, and a Return on Invested Capital (ROIC) of -2806.06%. Per share, it reports EPS of $-1.10, diluted EPS of $-1.10, free cash flow per share of $-1.07, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -100.00% year-over-year, net income growth of -49.19% year-over-year, and EPS growth of -49.19% year-over-year. On the balance sheet, it maintains a current ratio of 4.70x, a quick ratio of 4.16x, working capital of $2.55M, a debt-to-equity ratio of 0.27x, a debt ratio of 0.21, an interest coverage ratio of -97.53x, free cash flow of $-3.91M (TTM), and net debt of $-2.17M. Figures sourced from SEC EDGAR.
- Market Cap
- $6.21M
- P/E TTM
- -1.54x
- EPS TTM
- $-1.10
- P/B TTM
- 2.43x
- ROE TTM
- -98.74%
- ROA TTM
- -85.74%
- Debt To Equity
- 0.27x
- Free Cash Flow TTM
- $-3.91M
- Net Revenue TTM Growth 1Y
- -100.00%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Pulmatrix, Inc. in?
Pulmatrix, Inc. (PULM) operates in the Pharmaceutical Preparations industry.
What exchange does PULM trade on?
Pulmatrix, Inc. (PULM) trades on the Nasdaq.
Where is Pulmatrix, Inc. incorporated?
Pulmatrix, Inc. is incorporated in DE.
When was Pulmatrix, Inc. (PULM)'s most recent SEC filing?
Pulmatrix, Inc. (PULM)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13.
What is PULM's market cap?
Pulmatrix, Inc. (PULM) has a market capitalization of $6.21M as of 2026-06-30.
What is PULM's EPS (earnings per share)?
Pulmatrix, Inc. (PULM)'s trailing twelve month EPS is $-1.10 as of 2026-06-30.
What is PULM's ROE (return on equity)?
Pulmatrix, Inc. (PULM)'s trailing twelve month Return on Equity (ROE) is -98.74% as of 2026-06-30.
What is PULM's ROA (return on assets)?
Pulmatrix, Inc. (PULM)'s trailing twelve month Return on Assets (ROA) is -85.74% as of 2026-06-30.
What is PULM's ROIC (return on invested capital)?
Pulmatrix, Inc. (PULM)'s trailing twelve month Return on Invested Capital (ROIC) is -2806.06% as of 2026-06-30.
What is PULM's EV/EBITDA?
Pulmatrix, Inc. (PULM)'s trailing twelve month EV/EBITDA is -0.98x as of 2026-06-30.